Altimmune Inc (ALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
09-2005 | 06-2005 | |
Sales | 206 | 0 |
Gross Profit | 206 | N/A |
Operating Expenses | 50 | 0 |
Operating Income | 157 | N/A |
Other Income | 0 | -3 |
Pre-tax Income | 157 | -3 |
Income Tax | 10 | N/A |
Net Income Continuous | 147 | -3 |
Net Income | $147 | $-3 |
EPS Basic Total Ops | 6.01 | -0.33 |
EPS Basic Continuous Ops | 5.37 | -0.33 |
EPS Diluted Total Ops | 6.01 | N/A |
EPS Diluted Continuous Ops | 5.37 | N/A |
EBITDA(a) | $157 | $N/A |